FDA grants breakthrough status to Medtronic’s Valiant TAAA stent

Medtronic’s stent is intended to provide an off-the-shelf endovascular solution for treating a thoracoabdominal aortic aneurysm. Credit: Medtronic plc.



  • FDA grants breakthrough status to Medtronic’s Valiant TAAA stent